Feasibility of Behavioral Intervention and Guided Stepping Training Early Post-Stroke (BIG STEPS): A Pilot Randomized Trial.
Victor E Ezeugwu, Mona Iyizoba, Asya Shiloff-Rogers and 6 others
PMID 42769401WHAT IT FOUND
Early stepping training after stroke was feasible and safe, with participants averaging 6534 steps/day versus 4031 in the control group at 12 weeks.
This pilot supports larger trials but does not yet prove lasting functional gains.
Key findings
01Feasibility metrics met predefined criteria, with high retention and adherence to the intervention and monitoring devices.
02Participants receiving the early intervention accumulated significantly more daily steps and less sedentary time compared to the waitlist control at the 12-week endpoint.
03No serious adverse events were attributed to the intervention, and fall rates were comparable between the early treatment and control groups.
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for OTs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study was a pilot with a small sample size (n=28), limiting statistical power and generalizability. Participants and therapists were not blinded to the intervention, which may introduce bias in adherence and self-reported outcomes. The intervention included usual care physical therapy, which varied between groups (median 4 sessions for early group vs 11 for delayed group before crossover), making it difficult to isolate the specific effect of BIG STEPS from the total dose of therapy. Acceptability was inferred from adherence rates rather than assessed through qualitative interviews. Exploratory outcomes showed large effects on step counts but minimal differences in functional walking tests and patient-reported outcomes at the primary endpoint.
Declared interests
The investigators reported no financial or nonfinancial disclosures.
The easy way to misread this
Do not interpret the large increase in daily steps as evidence of improved walking capacity or functional recovery. The primary outcome was feasibility, and the trial was not powered to detect differences in clinical walking tests, which showed negligible between-group effects at 12 weeks.